Two-year secondary endpoints were recurrent hospitalizations for heart failure and freedom from death due to any cause or the ...

Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received ...

Two-year secondary endpoints were recurrent hospitalizations for heart failure and freedom from death due to any cause or the need for tricuspid valve surgery or another valve-repair procedure.

Edwards Lifesciences (NYSE:EW) announced today that it received CE mark approval for its Sapien M3 mitral valve replacement ...

TRILUMINATE's primary endpoint was a hierarchical composite of death from any cause or tricuspid valve surgery, ...

The recommendations are similar to those recently announced for TTVR, with the final NCD for T-TEER expected by July.

Abbott (NYSE: ABT) today announced data demonstrating substantial, sustained improvements with its TriClip system.

After seeking help at MedStar Union Memorial Hospital, Mertz was diagnosed with the condition and was told she would need a tricuspid valve replacement. Normally, this type of surgery requires ...

Surgical repair or replacement of the tricuspid valve is usually deferred unless cardiac surgery is being done for other purposes, such as repair or replacement of the mitral or aortic valves.

Repair of the tricuspid valve in severe tricuspid regurgitation when mitral valve surgery is planned (class I, level of evidence B). Tricuspid valve replacement or annuloplasty ring is reasonable ...